Axsome Therapeutics Stock News

Axsome Therapeutics Inc (NASDAQ:AXSM) Director Mark Coleman purchased 650 shares of the stock in a transaction on Monday, June 29th. The shares were purchased at an average cost of $78.50 per share, f

Voloridge Investment Management LLC acquired a new stake in shares of Axsome Therapeutics Inc (NASDAQ:AXSM) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange

The FDA bestows a Breakthrough Therapy status on Axsome's (AXSM) AXS-05 for the treatment of Alzheimer's disease agitation. Shares rise.

Some traders appear to be taking profits off the table after the stock's jump last week.

The drugmaker received good news from the FDA for one of its pipeline candidates.

Axsome Therapeutics, Inc. (AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today announced that the U.S. Food and Drug Admin

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 25) Brainstorm Cell...

Two Sigma Advisers LP increased its stake in Axsome Therapeutics Inc (NASDAQ:AXSM) by 342.3% in the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 118,100

Axsome is planning to submit NDAs later this year for its 2 leading indications. These 2 indications alone have projected peak sales up to $3 billion, but Axsom

Alliancebernstein L.P. grew its position in shares of Axsome Therapeutics Inc (NASDAQ:AXSM) by 11.9% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Comm

AlphaCrest Capital Management LLC purchased a new position in shares of Axsome Therapeutics Inc (NASDAQ:AXSM) in the 1st quarter, Holdings Channel reports. The institutional investor purchased 3,800 s

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes

Sowell Financial Services LLC cut its holdings in shares of Axsome Therapeutics Inc (NASDAQ:AXSM) by 48.8% during the first quarter, Holdings Channel.com reports. The institutional investor owned 844

State Street Corp increased its stake in shares of Axsome Therapeutics Inc (NASDAQ:AXSM) by 5.0% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 661,315 shares